On the contrary, ribosomal S6 protein kinase 4 (RSK4) promotes CSC properties in esophageal squamous cell carcinoma (ESCC) by activating the Wnt/β-catenin pathway [32]. This evidence concerns the gene RPS6KA6 and esophageal squamous cell carcinoma.